Skip to main content
main-content

Spondyloarthropathies

medwireNews feature

Tofacitinib black box warning: A cause for concern?

Pills in question mark

Roy Fleischmann puts the new FDA boxed warning of increased pulmonary embolism and death risk with tofacitinib into context for rheumatologists and their patients.

medwireNews feature

Into the clinic: Certolizumab pegol for nonradiographic axSpA

Prescription

medwireNews talks to Walter Maksymowych and Marina Magrey about the impact of the recent FDA approval of certolizumab pegol for nonradiographic axial spondyloarthritis, and why the approval happened so much later in the USA than in Europe.

Expert Opinion: Editorial

Methotrexate versus etanercept as first-line therapy for psoriatic arthritis

Syringe and white pills on blue background

William Tillett, Deepak Jadon, and Jobie Evans debate the clinical reasons relating to the efficacy, safety, and practicality of using etanercept or methotrexate as first-line therapy for psoriatic arthritis.

medwireNews top story

Positive secukinumab results for axial manifestations in PsA

Spine

Secukinumab improves axial manifestations in patients with psoriatic arthritis and an inadequate response to nonsteroidal anti-inflammatory drugs, primary analysis of the phase III MAXIMISE trial shows.

EULAR 2019

Bimekizumab trials in spondyloarthritis

Doctor and needle

23-07-2019 | Axial spondyloarthritis | Feature | Article

Into the clinic: Certolizumab pegol for nonradiographic axSpA

medwireNews talks to Walter Maksymowych and Marina Magrey about the impact of the recent FDA approval of certolizumab pegol for nonradiographic axial spondyloarthritis, and why the approval happened so much later in the USA than in Europe.

15-06-2019 | Psoriatic arthritis | EULAR 2019 | Article

Researcher comment: The SPIRIT-H2H trial

Lead investigator Philip Mease discusses the findings from the SPIRIT-H2H trial, a phase III head-to-head trial of ixekizumab versus adalimumab in patients with psoriatic arthritis (7:15).

12-06-2019 | Psoriatic arthritis | EULAR 2019 | Article

Researcher comment: Tildrakizumab shows promise for PsA

Lead investigator Philip Mease outlines the results of a phase IIb trial supporting further development of the anti-interleukin-23p19 monoclonal antibody tildrakizumab for the treatment of psoriatic arthritis (8:45).

Themed collections

29-01-2018 | Biosimilars | Themed collection | Collection

Biosimilars

This content collection provides an overview of biosimilars in rheumatology, with a focus on switching between biosimilars and their originators, as well as discussions on safety and monitoring/pharmacovigilance, and a look at the pharmacoeconomics of biosimilars.

Journal articles and book chapters

23-11-2018 | Psoriatic arthritis | Article

Assessing disease activity in psoriatic arthritis: A literature review

Tucker LJ et al. Rheumatol Ther 2018. doi: 10.1007/s40744-018-0132-4

31-10-2018 | Psoriatic arthritis | ACR/ARHP 2018 | Article

From the Editorial Board: Highlights from the 2018 ACR/ARHP Annual Meeting

Editorial board members Oliver FitzGerald and Fernando Pérez-Ruiz provide their highlights from the spondyloarthropathy and crystal arthropathy sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA.

Guidelines

A convenient single access point, providing rheumatology professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Images and illustrations

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for rheumatology healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within rheumatology management, as recommended by our Editorial Board.

Image Credits